Michel Vounatsos

Director/Board Member bei REVVITY, INC.

Vermögen: 15 Mio $ am 30.04.2024

62 Jahre

Health Technology

Consumer Services

Aktive Positionen von Michel Vounatsos

Unternehmen	Position	Beginn	Ende
REVVITY, INC.	Director/Board Member	01.03.2020	-
REVVITY, INC.	Independent Dir/Board Member	01.03.2020	-
ZAI LAB LIMITED	Director/Board Member	07.01.2023	-
ZAI LAB LIMITED	Independent Dir/Board Member	07.01.2023	-
Biogen Idec, Inc. (North Carolina) Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.	Director/Board Member	06.01.2017	-
	Chief Executive Officer	06.01.2017	-
	Corporate Officer/Principal	18.04.2016	06.01.2017
Biogen GmbH Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos.	Director/Board Member	01.01.2017	-
	Chief Executive Officer	-	-
L’Institut de RYthmologie et Modélisation Cardiaque	Chairman	-	-
L’Institut de RYthmologie et Modélisation Cardiaque	Director/Board Member	-	-
n-Lorem Foundation	Director/Board Member	-	-
Revvity BV Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium.	Director/Board Member	-	-

Karriereverlauf von Michel Vounatsos

Ehemalige bekannte Positionen von Michel Vounatsos

Unternehmen	Position	Beginn	Ende
BIOGEN INC.	Director/Board Member	06.01.2017	14.11.2022
	Chief Executive Officer	06.01.2017	14.11.2022
	Corporate Officer/Principal	18.04.2016	06.01.2017
MERCK & CO., INC.	Corporate Officer/Principal	01.01.2008	01.04.2016

Ausbildung von Michel Vounatsos

École des Hautes Études Commerciales de Paris

Masters Business Admin

Statistik

International

Vereinigte Staaten	6
Frankreich	3
Belgien	2

Operativ

Director/Board Member	8
Chief Executive Officer	3
Corporate Officer/Principal	3

Sektoral

Health Technology	8
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Unternehmensverbindungen

Börsennotierte Unternehmen	4
MERCK & CO., INC.	Health Technology
BIOGEN INC.	Health Technology
REVVITY, INC.	Health Technology
ZAI LAB LIMITED	Health Technology

Private Unternehmen	5
Biogen Idec, Inc. (North Carolina) Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.	Health Technology
Revvity BV Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium.	Health Technology
L’Institut de RYthmologie et Modélisation Cardiaque
n-Lorem Foundation
Biogen GmbH Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos.	Health Technology

Sehen Sie sich die Unternehmensverbindungen an